Atopic Dermatitis Treatment Challenges: Pediatric vs. Adult Patient Management and Healthcare Resource Utilization

This panel discussion explored the complex challenges and opportunities associated with managing atopic dermatitis (AD), particularly in pediatric and adolescent populations. A key focus was the strategic use of topical treatments to reduce long-term healthcare costs and optimize resource use. Panelists highlighted that managing AD in children and teens is uniquely difficult due to parental hesitancy, adolescents' demand for quick results, and varying levels of compliance. Pediatric patients often face barriers to treatment access, especially when medications are not approved for younger age groups, and insurance hurdles further complicate timely care. In contrast, while adult patients may more easily access treatments, challenges persist, particularly among Medicare beneficiaries.

The discussion emphasized the critical need to align treatment choices with patient behavior, education, and long-term adherence. Many patients arrive with an array of previously used topicals, creating confusion and skepticism about new therapies. Education on proper application and realistic expectations is essential, as is clear communication to address misconceptions and treatment fatigue. The panel underscored the value of non-steroidal treatments to avoid side effects like skin thinning and HPA axis suppression, advocating for individualized care plans that prioritize both efficacy and patient understanding. Optimizing adherence and choosing treatments with better safety profiles can prevent unnecessary escalation to systemic therapies, ultimately lowering healthcare utilization.

Long-term delays in treating AD, especially in children, were shown to significantly affect quality of life and broader health outcomes. Uncontrolled eczema leads to chronic itch, sleep disruption, and heightened risk for infections and co-occurring conditions such as ADHD, anxiety, and depression. Early, consistent control of AD not only improves daily well-being but may also reduce the development of other atopic conditions like asthma or food allergies. The panel concluded that investing in accessible, effective topical treatments early in life could yield substantial health and economic benefits, highlighting the importance of strategic and timely care.